➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Johnson and Johnson
Harvard Business School
Colorcon
McKesson

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 5,688,760

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,688,760
Title: Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences
Abstract:Polypeptides comprising an N-terminal amino acid sequence corresponding to amino acids 107-111 of parathyroid hormone related protein (PTHrP) having bone resorption inhibitory activity are provided. The polypeptides are provided in pharmaceutical compositions for the treatment of diseases and disorders where inhibition of bone resorption is indicated.
Inventor(s): Kemp; Bruce E. (Kew, AU), Nicholson; Geoffrey C. (Geelong, AU), Martin; Thomas J. (Kew, AU), Fenton; Anna J. (Geelong, AU), Hammonds; R. Glenn (Berkeley, CA)
Assignee: Genentech, Inc. (San Francisco, CA) The University of Melbourne (Victoria, AU)
Application Number:08/064,111
Patent Claims:see list of patent claims

Details for Patent 5,688,760

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Genentech, Inc. (San Francisco, CA) The University of Melbourne (Victoria, AU) 2014-11-18 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Genentech, Inc. (San Francisco, CA) The University of Melbourne (Victoria, AU) 2014-11-18 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Genentech, Inc. (San Francisco, CA) The University of Melbourne (Victoria, AU) 2014-11-18 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Harvard Business School
Medtronic
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.